That said, GLP-1 medications for weight loss are not for everyone, and they can cause unpleasant, even serious, side effects, ...
You’re reading The Checkup With Dr. Wen, a newsletter on how to navigate medical and public health challenges. Click here to ...
The maker of the weight loss and diabetes drugs Wegovy and Ozempic has cut the prices for most versions of the blockbuster ...
Facing increased competition in the weight loss market and intense pressure from President Donald Trump, Novo Nordisk announced Monday that it is lowering prices for its blockbuster obesity and ...
The White House may have struck a deal with Eli Lilly and Novo Nordisk last week to lower the costs of their weight loss ...
Trump’s GLP-1 price deal slashes costs and expands selective Medicare coverage—threatening telehealth startups and sparking a ...
Senate Democrats are demanding that President Trump release the list of the most recent Medicare-negotiated drug prices.
The introduction of AbbVie’s hepatitis C drugs in 2014 forced Gilead’s hand in the fight for market dominance in hepatitis C.
Under30CEO on MSN
GLP-1 Prices Ease As Coverage Widens
Prices for GLP-1 medicines are starting to fall, and health plans are opening the door to more patients. The shift could reshape care for diabetes and obesity in the months ahead. Employers, insurers, ...
Novo Nordisk and Eli Lilly reached deals to lower GLP-1 drug costs for Medicare and Medicaid patients under Trump’s new ...
President Trump hailed his deal with pharma companies on GLP-1 drug pricing. The question is how big of a difference the deal ...
With new agreements from President Donald Trump promising lower prices on popular weight-loss drugs, the use of GLP-1 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback